Taichung Veterans General Hospital
Taichung, Taiwan
NCT Number: NCT07658131
This multicenter retrospective study aims to externally validate an artificial intelligence-aided weaning software developed using intensive care unit data from Taichung Veterans General Hospital between 2015 and 2019. The model predicts the optimal timing for extubation using routinely collected clinical variables including ventilator parameters, physiologic measurements, and fluid and nutrition information. De-identified data from four hospitals collected between 2020 and 2024 will be used to evaluate model performance. Performance metrics include sensitivity, specificity, accuracy, area under the receiver operating characteristic curve (AUROC), and F1 score.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Taichung, Taiwan
Critical care generates a large amount of digitized clinical data that may benefit from artificial intelligence-assisted decision support. The AI-Aided Weaning Software was previously developed using ICU data from Taichung Veterans General Hospital collected between 2015 and 2019.
This retrospective multicenter validation study will evaluate the external performance of the established model using independent datasets from four hospitals in Taiwan, including Taichung Veterans General Hospital, Mackay Memorial Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, and Tungs' Taichung MetroHarbor Hospital.
The study population includes adult ICU patients with respiratory failure who received mechanical ventilation for at least 72 hours between January 2020 and December 2024. De-identified routine clinical records will be collected according to a predefined case report form and analyzed centrally.
The primary objective is to assess the external validity of the AI-Aided Weaning Software across different hospitals. Model performance will be evaluated using sensitivity, specificity, accuracy, AUROC, and F1 score.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Using data collected during ICU admission
Area under the receiver operating characteristic curve (AUROC) for predicting successful extubation. AUROC ranges from 0.5 to 1.0, with higher values indicating better discriminative performance of the prediction model.
Time frame: ICU admission
SensitivitySensitivity of the prediction model for successful extubation. Sensitivity ranges from 0 to 1 (or 0% to 100%), with higher values indicating better identification of patients who achieve successful extubation.
Time frame: ICU admission
Specificity of the prediction model for successful extubation. Specificity ranges from 0 to 1 (or 0% to 100%), with higher values indicating better identification of patients who do not achieve successful extubation.
Time frame: ICU admission
Accuracy of the prediction model for successful extubation. Accuracy ranges from 0 to 1 (or 0% to 100%), with higher values indicating better overall prediction performance.
Time frame: ICU admission
F1 score of the prediction model for successful extubation. F1 score ranges from 0 to 1, with higher values indicating better balance between precision and recall.
Taichung Veterans General Hospital
Other
Using Multicenter Retrospective Data to Validate the Performance of AI-Aided Weaning Software
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07380607
Critical Illness, Disease Attributes
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT07313956
Critical Illness, Disease Attributes
Chicago, Illinois, United States
View Trial DetailsNCT07001696
Critical Illness, Disease Attributes
Zagazig, Al Sharqia, Egypt
View Trial DetailsNCT07411976
Critical Illness, Disease Attributes
Nîmes, France
View Trial Details